Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2026-01-05 @ 6:35 PM
Study NCT ID:
NCT03297593
Status:
COMPLETED
Last Update Posted:
2025-06-06
First Post:
2017-09-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma
Sponsor:
Swiss Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-14
First Submit QC Date:
None
Study First Post Date:
2017-09-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-05
Last Update Post Date:
2025-06-06
Last Update Post Date Type:
ACTUAL